Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

OsteoVation Impact

K-Number: K162864 · 2017-01-13

Decision Date2017-01-13
Product CodeGXP
Advisory CommitteeNE
DecisionSubstantially Equivalent

Device Summary

OsteoVation Impact is the device name listed in this FDA 510(k) record. The listed applicant is Skeletal Kinetics, LLC. It received FDA 510(k) clearance on 2017-01-13 under 510(k) number K162864. The device is classified under product code GXP. It was reviewed by the NE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the OsteoVation Impact?

OsteoVation Impact is a medical device that received FDA 510(k) clearance on 2017-01-13. The listed applicant is Skeletal Kinetics, LLC. The 510(k) number is K162864.

When did OsteoVation Impact receive FDA 510(k) clearance?

OsteoVation Impact received FDA 510(k) clearance on 2017-01-13, under 510(k) number K162864.

Who is the listed applicant for OsteoVation Impact?

The FDA 510(k) record lists Skeletal Kinetics, LLC as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for OsteoVation Impact?

The FDA product code for OsteoVation Impact is GXP.

Related Devices (Code: GXP)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.